In a report issued on June 2, Rishi Jaluria from RBC Capital maintained a Buy rating on Veeva Systems (VEEV – Research Report), with a price target of $250.00. The company’s shares closed last Friday at $187.97.
According to TipRanks.com, Jaluria is a 3-star analyst with an average return of 3.5% and a 46.2% success rate. Jaluria covers the Technology sector, focusing on stocks such as Clearwater Analytics Holdings, Zoom Video Communications, and Duck Creek Technologies.
Currently, the analyst consensus on Veeva Systems is a Moderate Buy with an average price target of $221.94, representing a 17.1% upside. In a report issued on May 31, Citigroup also maintained a Buy rating on the stock with a $210.00 price target.
The company has a one-year high of $343.96 and a one-year low of $152.04. Currently, Veeva Systems has an average volume of 1.16M.
Based on the recent corporate insider activity of 113 insiders, corporate insider sentiment is negative on the stock. This means that over the past quarter there has been an increase of insiders selling their shares of VEEV in relation to earlier this year. Most recently, in April 2022, Ronald Codd, a Director at VEEV sold 20,000 shares for a total of $4,142,742.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
Founded in 2007 and headquartered in California, Veeva Systems, Inc. is a leader in cloud-based software for the global life sciences industry. Its solutions are focused on pharmaceutical and life sciences industry applications.
Read More on VEEV: